Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 14 Carcinoma, Non-Small-Cell Lung 14 Brain Neoplasms 12 Sarcoma 7 Meningioma 6 Glioma 6 Pancreatic Neoplasms 5 Lung Neoplasms 5 Esophageal Neoplasms 5 Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 4 Glioblastoma 4 Carcinoma, Hepatocellular 4 Solid Tumor, Adult 3 Rhabdomyosarcoma 3 Radiation Injuries 3 Liver Neoplasms 3 Head and Neck Neoplasms 3 Chondrosarcoma 3 Uterine Cervical Neoplasms 2 Thymus Neoplasms 2 Solid Tumor 2 Prostate Adenocarcinoma 2 Pituitary Neoplasms 2 Pinealoma 2 Osteosarcoma 2 Oligodendroglioma 2 Nerve Sheath Neoplasms 2 Nasopharyngeal Carcinoma 2

Interventions

Cyclophosphamide 7 pembrolizumab 6 Radiotherapy 6 Cisplatin 6 Sunitinib 5 Carboplatin 5 Paclitaxel 4 Thymectomy 3 130-nm albumin-bound paclitaxel 3 selinexor 2 lenvatinib 2 fludarabine 2 Taxes 2 Robotic Surgical Procedures 2 Ramucirumab 2 Prednisone 2 Pemetrexed 2 Octreotide 2 Nivolumab 2 N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide 2 Methylprednisolone 2 Imatinib Mesylate 2 Etoposide 2 Erlotinib Hydrochloride 2 Drug Therapy 2 Doxorubicin 2 Chemoradiotherapy 2 Celecoxib 2 zimberelimab 1 vorolanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Thymoma × Proton Therapy × Clear all

NCT04822077 2021-03-30

PROTHYM

Swedish Lung Cancer Study Group

Phase NA Recruiting

Thymoma, Thymus Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡